search this site
- home
- highlights
- sinclair at a glance
- growing our operations worldwide
- products:oral health
- products:dermatology
- chairman´s statement
- business review:operational
- business review:financial
- board of directors
- senior management
- directors´ report
- corporate governance report
- directors´ remuneration report
- independent auditors´ report
- consolidated income statement
- balance sheets
- statements of changes in shareholders´ equity
- cash flow statements
- notes to the financial statements
- 1. Accounting Policies
- 2. Financial risk management
- 3. Segmental information
- 4. Exceptional operating items
- 5. Operating profit/(loss)
- 6. Employees and Directors
- 7. Finance Income and costs
- 8. Taxation on Loss on ordinary activites
- 9. Loss for the financial year
- 10. Earnings/(Loss) per Share
- 11. Goodwill
- 12. Intangible assets
- 13. Property, plant and equipment
- 14. Investments
- 15. Inventories
- 16. Trade and other receivables
- 17. Trade and other payables
- 18. Borrowings
- 19. Non-current tax
- 20. Financial Instruments
- 21. Called-up share capital
- 22. Options and Warrants over Shares of Sinclair Pharma plc
- 23. Share-based payments
- 24. Other Reserves
- 25. Cash Flows from Operating Activities
- 26. Operating lease commitments
- 27. Capital Commitments
- 28. Related Party Transactions
- corporate advisors
7. FINANCE INCOME AND COSTS
2008 |
2007 |
|
£'000 |
£'000 |
|
| Finance costs | ||
| Interest on bank loans and overdrafts | (326) |
(63) |
| Interest due on finance leases | (41) |
(43) |
| Net foreign exchange losses on financing activities | (338) |
— |
| Unwinding of discount on contingent consideration for Groupe CS Dermatologie | (18) |
(17) |
| Other finance charges | (18) |
(6) |
| Exceptional finance costs | (330) |
— |
| Finance costs | (1,071) |
(129) |
| Finance income | ||
| Bank interest receivable | 22 |
81 |
| Interest receivable on tax refund regarding Groupe CS Dermatologie – exceptional item | 380 |
— |
| Other finance income | 45 |
14 |
| Finance income | 447 |
95 |
| Net finance expense | (624) |
(34) |
Exceptional finance costs relate to costs incurred during the year in arranging finance facilities that the Directors decided not to enter into in October 2008 as the terms were unfavourable and which have therefore been written off in these financial statements.